AstraZeneca PLC logo

AstraZeneca PLC

$ 66.21 +0.04 (+0.06%) 10:08 PM EST
P/E:
101.08
P/B:
5.48
Market Cap:
$ 206.37B
Enterprise V:
$ 229.97B
Volume:
2.88M
Avg Vol (2M):
6.22M
Also Trade In:
Volume:
2.88M
Market Cap $:
206.37B
PE Ratio:
101.08
Avg Vol (2-Month):
6.22M
Enterprise Value $:
229.97B
PB Ratio:
5.48
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its sales.

Financials (Next Earnings Date:2023-02-09)

AZN's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:AZN

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 45,154
EPS (TTM) ($) 0.655
Beta 0.54
Volatility % 24.05
14-Day RSI 73.4
14-Day ATR ($) 1.250134
20-Day SMA ($) 63.067
12-1 Month Momentum % 3.76
52-Week Range ($) 52.65 - 71.7
Shares Outstanding (Mil) 3,099.03

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

AstraZeneca PLC Filings

Document Form Filing Date
No Filing Data

AstraZeneca PLC Analysis

Share your research

Headlines

See More
No news.